KE Meyer | AMiner学者主页

全面呈现 [KE Meyer] 的学术影响力

深度挖掘高质量成果与权威引用，让优秀看得见

研究兴趣

暂无数据

论文（8）

专利

基金项目

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1Preclinical studies with the commercial preparation of botulinum toxin type B using the mouse hindlimb paralysis model

KE Meyer, J Lugar, ZM Liao,CA Gasper, EJ Stockwell

2002NEUROLOGY（2002）

引用

AI阅读

2The duration of paralysis in the trapezius muscle induced by botulinum toxins in the cynomolgus monkey

JC Arezzo,MS Litwak,KE Meyer,GM Shopp

2002NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY（2002）

引用

AI阅读

3A Comparison of Water Consumption Following a Single Intramuscular Injection of Equiparalytic Doses of NeuroBloc™ (botulinum Toxin Type B) and Botox® (botulinum Toxin Type A) in Mice

K. E. Meyer, J. Lugar,Z. Liao, C. A. Gasper, E. J. Stockwell, B. M. Quast, W. K. Dunn,L. C. Mutter,G. M. Shopp,S. B. Freedman

European Journal of NeurologyVolume 8, Issue s4 p. 25-25 A comparison of water consumption following a single intramuscular injection of equiparalytic doses of NeuroBloc™ (botulinum toxin type B) and Botox® (botulinum toxin type A) in mice K. E. Meyer, K. E. Meyer Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorJ. Lugar, J. Lugar Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorZ. Liao, Z. Liao Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorC. A. Gasper, C. A. Gasper Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorE. J. Stockwell, E. J. Stockwell Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorB. M. Quast, B. M. Quast Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorW. K. Dunn, W. K. Dunn Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorL. C. Mutter, L. C. Mutter Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorG. M. Shopp, G. M. Shopp Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorS. B. Freedman, S. B. Freedman Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this author K. E. Meyer, K. E. Meyer Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorJ. Lugar, J. Lugar Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorZ. Liao, Z. Liao Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorC. A. Gasper, C. A. Gasper Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorE. J. Stockwell, E. J. Stockwell Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorB. M. Quast, B. M. Quast Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorW. K. Dunn, W. K. Dunn Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorL. C. Mutter, L. C. Mutter Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorG. M. Shopp, G. M. Shopp Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorS. B. Freedman, S. B. Freedman Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this author First published: 01 May 2002 https://doi.org/10.1046/j.1468-1331.2001.00008.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume8, Issues4May 2001Pages 25-25 RelatedInformation

2001European Journal of Neurology（2001）

引用

AI阅读

4Botulinum toxin type B (BoNT-B): Safety studies in adult and juvenile cynomolgus monkeys

JC Arezzo,M Litwak, FA Caputo,KE Meyer,CA Gasper,GM Shopp

2001NEUROLOGY（2001）

引用

AI阅读

5Spread of paralytic effects of BoNT-A versus BoNT-B in juvenile cynomolgus monkeys

JC Arezzo,MS Litwak, FA Caputo,GM Shopp,KE Meyer

2001ANNALS OF NEUROLOGY（2001）

引用

AI阅读

6Spread of Paralytic Activity of Neurobloc™ (botulinum Toxin Type B) and Botox® (botulinum Toxin Type A) in Juvenile Monkeys: an Electrophysiological Model

J. C. Arezzo,M. S. Litwak, F. A. Caputo, C. A. Gasper,G. M. Shopp,K. E. Meyer

European Journal of NeurologyVolume 8, Issue s4 p. 26-26 Spread of paralytic activity of neurobloc™ (botulinum toxin type B) and botox® (botulinum toxin type A) in juvenile monkeys: an electrophysiological model J. C. Arezzo, J. C. Arezzo Albert Einstein College of Medicine, Bronx, NY;Search for more papers by this authorM. S. Litwak, M. S. Litwak Albert Einstein College of Medicine, Bronx, NY;Search for more papers by this authorF. A. Caputo, F. A. Caputo Sierra Biomedical Inc., Sparks, NV;Search for more papers by this authorC. A. Gasper, C. A. Gasper Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorG. M. Shopp, G. M. Shopp Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorK. E. Meyer, K. E. Meyer Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this author J. C. Arezzo, J. C. Arezzo Albert Einstein College of Medicine, Bronx, NY;Search for more papers by this authorM. S. Litwak, M. S. Litwak Albert Einstein College of Medicine, Bronx, NY;Search for more papers by this authorF. A. Caputo, F. A. Caputo Sierra Biomedical Inc., Sparks, NV;Search for more papers by this authorC. A. Gasper, C. A. Gasper Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorG. M. Shopp, G. M. Shopp Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this authorK. E. Meyer, K. E. Meyer Elan Pharmaceuticals Inc., South San Francisco, CA, USASearch for more papers by this author First published: 01 May 2002 https://doi.org/10.1046/j.1468-1331.2001.00010.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume8, Issues4May 2001Pages 26-26 RelatedInformation

2001European Journal of Neurology（2001）

引用

AI阅读

7Drug discrimination study of zonisamide.

JL Wiley,KE Meyer,RL Balster

1999EPILEPSIA（1999）

引用

AI阅读

8Self-administration study of zonisamide in rhesus monkeys.

RL Balster, ME Dance,KE Meyer

1999EPILEPSIA（1999）

引用